---
trial_id: 954
discovery_date: 2022-06-20 15:00:57.408773
date: 2022-06-20 15:00:57.408773
title: "A Phase I&#x2F;Ib, Open-label, Multi-center Study of DFF332 as a Single Agent and in Combination With Everolimus or IO Agents in Patients With Advanced&#x2F;Relapsed ccRCC and Other Malignancies With HIF2Î± Stabilizing Mutations"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04895748'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
